QCG
VKTX icon

Quadrant Capital Group’s Viking Therapeutics VKTX Stock Holding History

Quadrant Capital Group’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,021
Closed -$65.8K – 2547
2026
Q1 		$65.8K Buy
2,021
+858
+74% +$27.6K ﹤0.01% 1608
2025
Q4 		$40.9K Buy
1,163
+24
+2% +$850 ﹤0.01% 1756
2025
Q3 		$29.9K Buy
+1,139
New +$34K ﹤0.01% 1825
2025
Q2 		– Sell
-1,638
Closed -$39.6K – 2590
2025
Q1 		$39.6K Buy
1,638
+296
+22% +$9.36K ﹤0.01% 1793
2024
Q4 		$54K Buy
1,342
+248
+23% +$14.1K ﹤0.01% 1372
2024
Q3 		$69.3K Sell
1,094
-5
-0.5% -$293 ﹤0.01% 1278
2024
Q2 		$58.3K Sell
1,099
-7
-0.6% -$459 ﹤0.01% 1327
2024
Q1 		$90.7K Sell
1,106
-286
-21% -$12.7K 0.01% 1065
2023
Q4 		$25.9K Hold
1,392
– – ﹤0.01% 1698
2023
Q3 		$15.4K Hold
1,392
– – ﹤0.01% 1815
2023
Q2 		$22.6K Sell
1,392
-883
-39% -$18.5K ﹤0.01% 1658
2023
Q1 		$37.9K Sell
2,275
-294
-11% -$3.04K ﹤0.01% 1387
2022
Q4 		$24.1K Sell
2,569
-89
-3% -$397 ﹤0.01% 1570
2022
Q3 		$7K Sell
2,658
-389
-13% -$1.27K ﹤0.01% 2042
2022
Q2 		$9K Buy
3,047
+2,745
+909% +$6.79K ﹤0.01% 1744
2022
Q1 		$1K Buy
302
+277
+1,108% +$994 ﹤0.01% 2407
2021
Q4 		$0 Hold
25
– – ﹤0.01% 2708
2021
Q3 		$0 Hold
25
– – ﹤0.01% 2661
2021
Q2 		$0 Buy
+25
New +$148 ﹤0.01% 2576

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quadrant Capital Group's VKTX Position: Q2 2026 in Review

Quadrant Capital Group sold out of Viking Therapeutics (VKTX) in Q2 2026, closing a stake of 2,021 shares — an estimated $65.8K sold.

Quadrant Capital Group first reported a position in VKTX in Q2 2021 and held it in 19 quarters. The position peaked at $90.7K in Q1 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Quadrant Capital Group reported no remaining Viking Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 2,021 Viking Therapeutics shares in Q2 2026, an estimated $65.8K.
  • Quadrant Capital Group first reported a position in Viking Therapeutics in Q2 2021 and held it in 19 quarters.
  • Quadrant Capital Group's Viking Therapeutics position peaked at $90.7K in Q1 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.